Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Risto O. Juvonen, Mira Kuusisto, Carolin Fohrgrup, Mari H. Pitkänen, Tapio J. Nevalainen, Seppo Auriola, Hannu Raunio, Markku Pasanen & Olli T. Pentikäinen. (2016) Inhibitory effects and oxidation of 6-methylcoumarin, 7-methylcoumarin and 7-formylcoumarin via human CYP2A6 and its mouse and pig orthologous enzymes. Xenobiotica 46:1, pages 14-24.
Read now
Read now
H. Raunio, N. Pokela, K. Puhakainen, M. Rahnasto, T. Mauriala, S. Auriola & R. O. Juvonen. (2008) Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo. Xenobiotica 38:1, pages 34-47.
Read now
Read now
M. Rahnasto, H. Raunio, A. Poso & R. O. Juvonen. (2003) More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde. Xenobiotica 33:5, pages 529-539.
Read now
Read now
M. Rypka, J. Veselý, Z. Chmela, D. Riegrová, K. Červenková, L. Havlíček, K. Lemr, J. Hanuš, B. Černý, J. Lukeš & K. Michalíková. (2002) In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine by mouse liver microsomes. Xenobiotica 32:11, pages 1017-1031.
Read now
Read now
Articles from other publishers (15)
Xiao Deng, Qianghong Pu, Erhao Wang & Chao Yu. (2016) Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms. Oncology Letters 12:6, pages 5309-5314.
Crossref
Crossref
Suzanne van de Nobelen, Anne S. Kienhuis & Reinskje Talhout. (2016) An Inventory of Methods for the Assessment of Additive Increased Addictiveness of Tobacco Products: Table 1.. Nicotine & Tobacco Research 18:7, pages 1546-1555.
Crossref
Crossref
M. Shoaib & Y. Buhidma. 2016. Animal Models for Medications Screening to Treat Addiction. Animal Models for Medications Screening to Treat Addiction
121
156
.
Niina Tani, Risto O. Juvonen, Hannu Raunio, Muluneh Fashe, Jukka Leppänen, Bin Zhao, Rachel F. Tyndale & Minna Rahnasto-Rilla. (2014) Rational design of novel CYP2A6 inhibitors. Bioorganic & Medicinal Chemistry 22:23, pages 6655-6664.
Crossref
Crossref
Minna K. Rahnasto, Hannu A. Raunio, Carsten Wittekindt, Kaisa A. Salminen, Jukka Leppänen, Risto O. Juvonen, Antti Poso & Maija K. Lahtela-Kakkonen. (2011) Identification of novel CYP2A6 inhibitors by virtual screening. Bioorganic & Medicinal Chemistry 19:23, pages 7186-7193.
Crossref
Crossref
Alfonso T. García-Sosa, Sulev Sild, Kalev Takkis & Uko Maran. (2011) Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase. Journal of Chemical Information and Modeling 51:10, pages 2595-2611.
Crossref
Crossref
Yoshie Hirano & Takaharu Mizutani. (2003) Study of inhibition of CYP2A6 by some drugs derived from quinoline. Journal of Pharmacy and Pharmacology 55:12, pages 1667-1672.
Crossref
Crossref
Chunzhi Ai, Yan Li, Yonghua Wang, Wei Li, Peipei Dong, Guangbo Ge & Ling Yang. (2010) Investigation of binding features: Effects on the interaction between CYP2A6 and inhibitors. Journal of Computational Chemistry, pages NA-NA.
Crossref
Crossref
Antoinette Chougnet, Wolf-D. Woggon, Esther Locher & Boris Schilling. (2009) Synthesis and in vitro Activity of Heterocyclic Inhibitors of CYP2A6 and CYP2A13, Two Cytochrome P450 Enzymes Present in the Respiratory Tract. ChemBioChem 10:9, pages 1562-1567.
Crossref
Crossref
Helena A. Soini, Donald Wiesler, Sachiko Koyama, Christophe Féron, Claude Baudoin & Milos V. Novotny. (2009) Comparison of Urinary Scents of Two Related Mouse Species, Mus spicilegus and Mus domesticus. Journal of Chemical Ecology 35:5, pages 580-589.
Crossref
Crossref
Max K. Leong, Yen-Ming Chen, Hong-Bin Chen & Po-Hong Chen. (2008) Development of a New Predictive Model for Interactions with Human Cytochrome P450 2A6 Using Pharmacophore Ensemble/Support Vector Machine (PhE/SVM) Approach. Pharmaceutical Research 26:4, pages 987-1000.
Crossref
Crossref
M Rahnasto, C Wittekindt, R O Juvonen, M Turpeinen, A Petsalo, O Pelkonen, A Poso, G Stahl, H-D Höltje & H Raunio. (2007) Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme—an in silico approach. The Pharmacogenomics Journal 8:5, pages 328-338.
Crossref
Crossref
Michael RabinoffNicholas CaskeyAnthony RisslingCandice Park. (2007) Pharmacological and Chemical Effects of Cigarette Additives. American Journal of Public Health 97:11, pages 1981-1991.
Crossref
Crossref
Kimiko Aoki, Yasuharu Kashiwagura, Toru Horie, Hitoshi Sato, Chise Tateno, Naoki Ozawa & Katsutoshi Yoshizato. (2006) Characterization of Humanized Liver from Chimeric Mice Using Coumarin as a Human CYP2A6 and Mouse CYP2A5 Probe. Drug Metabolism and Pharmacokinetics 21:4, pages 277-285.
Crossref
Crossref
Arja Asikainen, Juhani Tarhanen, Antti Poso, Markku Pasanen, Esko Alhava & Risto O Juvonen. (2003) Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes. Toxicology in Vitro 17:4, pages 449-455.
Crossref
Crossref